Collective and individual migration following the epithelial–mesenchymal transition IY Wong, S Javaid, EA Wong, S Perk, DA Haber, M Toner, D Irimia Nature materials 13 (11), 1063-1071, 2014 | 204 | 2014 |
Association of anticholinergic burden with cognitive impairment and health care utilization among a diverse ambulatory older adult population NL Campbell, AJ Perkins, P Bradt, S Perk, RC Wielage, MA Boustani, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (11 …, 2016 | 102 | 2016 |
A metabolic index of ischemic injury for perfusion-recovery of cadaveric rat livers S Perk, ML Izamis, H Tolboom, B Uygun, F Berthiaume, ML Yarmush, ... PLoS One 6 (12), e28518, 2011 | 50 | 2011 |
Monte Carlo sampling and principal component analysis of flux distributions yield topological and modular information on metabolic networks B Sarıyar, S Perk, U Akman, A Hortaçsu Journal of Theoretical Biology 242 (2), 389-400, 2006 | 33 | 2006 |
Statistical monitoring of complex chemical processes using agent-based systems S Perk, F Teymour, A Cinar Industrial & Engineering Chemistry Research 49 (11), 5080-5093, 2010 | 32 | 2010 |
Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives RC Wielage, S Perk, NL Campbell, TM Klein, LM Posta, T Yuran, ... Journal of Medical Economics 19 (12), 1135-1143, 2016 | 31 | 2016 |
A fitness index for transplantation of machine-perfused cadaveric rat livers S Perk, ML Izamis, H Tolboom, B Uygun, ML Yarmush, K Uygun BMC Research Notes 5, 1-7, 2012 | 28 | 2012 |
Adaptive agent-based system for process fault diagnosis S Perk, F Teymour, A Cinar Industrial & engineering chemistry research 50 (15), 9138-9155, 2011 | 22 | 2011 |
An adaptive fault‐tolerant control framework with agent‐based systems S Perk, QM Shao, F Teymour, A Cinar International Journal of Robust and Nonlinear Control 22 (1), 43-67, 2012 | 17 | 2012 |
Estimated budget impact of increased use of mirabegron, a novel treatment for overactive bladder S Perk, RC Wielage, NL Campbell, TM Klein, A Perkins, LM Posta, ... Journal of Managed Care & Specialty Pharmacy 22 (9), 1072-1084, 2016 | 13 | 2016 |
Identifying gaps in the photographic record of the vascular plant flora of the Americas NCA Pitman, T Suwa, C Ulloa Ulloa, J Miller, J Solomon, J Philipp, ... Nature plants 7 (8), 1010-1014, 2021 | 11 | 2021 |
Batch process monitoring using multiblock multiway principal component analysis S Perk, A Çinar IFAC Proceedings Volumes 39 (2), 209-214, 2006 | 9 | 2006 |
Methods and compositions for preserving tissues and organs ML Yarmush, M Toner, ML Izamis, TA Berendsen, RM Bieganski, OB Usta, ... US Patent 10,575,515, 2020 | 7 | 2020 |
Enhancing the budget impact model for institutional use: a tool with practical applications for the hospital oncology pharmacy LM Hess, FN Cinfio, S Wetmore, C Churchill, C Fausel, A Ale-Ali, ... Hospital Pharmacy 51 (6), 452-460, 2016 | 7 | 2016 |
Machine perfusion enhances hepatocyte isolation yields from ischemic livers ML Izamis, S Perk, C Calhoun, K Uygun, ML Yarmush, F Berthiaume Cryobiology 71 (2), 244-255, 2015 | 7 | 2015 |
Monitoring, Analysis and Diagnosis of Distributed Processes with Agent-Based Systems S Perk, F Teymour, M North, E Tatara, M Altaweel IFAC Proceedings Volumes 42 (11), 637-642, 2009 | 7 | 2009 |
Preliminary phenotypic characterization of newly isolated halophilic microorganisms by footprinting: a rapid metabolome analysis B Sarıyar-Akbulut, A Salman-Dilgimen, S Ceylan, S Perk, AA Denizci, ... Archives of microbiology 189, 19-26, 2008 | 7 | 2008 |
Cost-effectiveness of insulin glargine 300 units/ml (GLA-300) vs insulin degludec 100 units/ml (IDEG) IN T2D D Murphy, X Yu, M Fournier, TM Klein, T Fan, S Perk, RON PREBLICK, ... Diabetes 66 (Supplement 1), A354, 2017 | 4 | 2017 |
Agent-based monitoring, fault detection, diagnosis and control of spatially distributed processes S Perk IFAC Proceedings Volumes 40 (5), 285-290, 2007 | 3 | 2007 |
OP0162-HPR Estimating health-related quality of life for gout patients: a post-hoc analysis of utilities from the clear trials F Pérez-Ruiz, A So, P Kandaswamy, R Karra, K Kelton, S Perk, T Bardin Annals of the Rheumatic Diseases 77 (Suppl 2), 132-132, 2018 | 2 | 2018 |